Part 2: Expanding Shipping Temperatures Without Sacrificing Quality: A Guide to Transport Validation and PQ
Demonstrating Product Quality All pharmaceutical manufacturers must ensure that the safety and efficacy of...
read Details
Understanding + Applying Annex 1: New EU GMP
Understanding + Applying Annex 1: New EU GMP
The global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
Receive this webinar to your email
You may also like
Part 1: The Foundation of Pharma Supply Chain Integrity
Introduction The integrity of supply chain management is pivotal in the demanding realm of...
read Details
Launching in the U.S.: FDA Transport Validation Compliance Essentials for European Manufacturers
Entering the U.S. market comes with a unique set of regulatory challenges, particularly when...
read Details